沉默调节蛋白3通过mTOR信号途径调节溶酶体功能抑制U87细胞凋亡

您当前的位置：

首页 >

文章列表页 >

沉默调节蛋白3通过mTOR信号途径调节溶酶体功能抑制U87细胞凋亡

基础医学 | 更新时间：2026-01-09

- 沉默调节蛋白3通过mTOR信号途径调节溶酶体功能抑制U87细胞凋亡
- Silent information regulator 3 modulates lysosome function to inhibit apoptosis of U87 cell by mTOR pathway
- 陆军军医大学学报 2023年45卷第18期页码：1916-1926
- 作者机构：
  
  1.710021 西安，西安医学院临床医学院：中尼友好拉吉姆医学实验室
  2.710021 西安，西安市肿瘤早诊创新转化重点实验室
  3.710021 西安，陕西省呼吸病预防与诊治工程研究中心
  4.710077 西安，西安医学院第一附属医院神经内科
- 作者简介：
  
  [Rajiv Kumar Jha，E-mail：rajivxjtu@gmail.com Rajiv Kumar Jha, E-mail: rajivxjtu@gmail.com
- 基金信息：
  
  陕西省高校科协青年托举计划项目(20200314);陕西省科技厅面上项目(2021JM-495);陕西省教育厅专项科研计划项目(21JK0890);大学生创新创业训练计划(S202111840075)
- DOI：10.16016/j.2097-0927.202306039
  中图分类号： R394.3;R730.23;R739.41
- 收稿：2023-06-13，
  
  修回：2023-07-12，
  
  纸质出版：2023-09-30
- 稿件说明：
移动端阅览
张旭东, 单李天一, 王蓉, 等. 沉默调节蛋白3通过mTOR信号途径调节溶酶体功能抑制U87细胞凋亡[J]. 陆军军医大学学报, 2023,45(18):1916-1926.

Xudong ZHANG, Litianyi SHAN, Rong WANG, et al. Silent information regulator 3 modulates lysosome function to inhibit apoptosis of U87 cell by mTOR pathway[J]. Journal of Army Medical University, 2023, 45(18): 1916-1926.
张旭东, 单李天一, 王蓉, 等. 沉默调节蛋白3通过mTOR信号途径调节溶酶体功能抑制U87细胞凋亡[J]. 陆军军医大学学报, 2023,45(18):1916-1926. DOI： 10.16016/j.2097-0927.202306039.

Xudong ZHANG, Litianyi SHAN, Rong WANG, et al. Silent information regulator 3 modulates lysosome function to inhibit apoptosis of U87 cell by mTOR pathway[J]. Journal of Army Medical University, 2023, 45(18): 1916-1926. DOI： 10.16016/j.2097-0927.202306039.

摘要

目的

2

探讨沉默调节蛋白3(sirtuin 3，Sirt3)在胶质瘤细胞U87中的作用，为胶质瘤的早期诊治提供新靶点。

方法

2

基于中国脑胶质瘤数据库(CGGA)、GEPIA2数据库，通过生物信息学分析Sirt3在胶质瘤不同分级的表达情况，通过Western blot检测6位胶质瘤患者癌旁与肿瘤组织中Sirt3的蛋白水平。利用shRNA慢病毒、CRISPR/Cas9系统干预U87细胞Sirt3的表达，采用TUNEL染色、PI-Annexin V双荧光标记检测细胞凋亡情况，Western blot检测凋亡相关蛋白Bax、Cleaved-caspase3及LAMP1、LAMP2、LAMP2A、TFEB、mTOR等蛋白的表达。利用mTOR小分子抑制剂Rapamycin处理Sirt3敲减U87细胞，检测相关蛋白及细胞凋亡的变化。对Sirt3敲除前后的U87细胞进行核质分离实验，并检测p-TFEB蛋白表达的变化。在敲减及敲除Sirt3的U87细胞中分别过表达TFEB及Sirt3后，检测溶酶体膜蛋白表达的变化情况。

结果

2

Sirt3在高级别胶质瘤中高表达，且与患者的低生存率密切相关。敲减Sirt3表达后细胞凋亡增加(

P

<

0.01)，溶酶体膜蛋白LAMP1、LAMP2、LAMP2A显著下调(

P

<

0.01)，p-mTOR显著增加(

P

<

0.01)，通过核质分离实验发现敲除Sirt3后p-TFEB在胞质中增加(

P

<

0.01)。在Sirt3敲除组过表达Sirt3后，LAMP1、LAMP2蛋白水平恢复，且溶酶体数量显著增加(

P

<

0.01)；在Sirt3敲减组过表达TFEB后，LAMPs蛋白表达明显上调(

P

<

0.01)。

结论

2

Sirt3可能通过调控mTOR信号通路影响TFEB的核质分布，上调溶酶体膜蛋白LAMPs表达增强胶质瘤细胞溶酶体功能，进而促进胶质瘤细胞存活和恶性增殖，提示Sirt3可能是胶质瘤临床诊断和进展的分子标志物。

Abstract

Objective

2

To investigate the role of silent information regulator 3 (Sirt3) in glioma U87 cells

and provide new targets for early diagnosis and treatment of glioma.

Methods

2

Based on the China Brain Glioma Database (CGGA) and GEPIA2 database

the expression of Sirt3 in different grades of glioma was analyzed by bioinformatics

and the protein level of Sirt3 in the adjacent and tumor samples of 6 glioma patients was further detected by Western blotting. Then

shRNA lentivirus and CRISPR/Cas9 system were used to interfere with the expression of Sirt3 in U87 cells

and TUNEL staining

PI-Annexin V double fluorescent labeling and Western blotting were used to detect the expression of apoptosis-related proteins(Bax

Cleaved-caspase3) and lysosome membrane proteins (LAMP1

LAMP2

LAMP2A)

TFEB

mTOR

and other proteins. Then mTOR small molecule inhibitor

rapamycin was employed to treat Sirt3 knockdown cells

the changes in related proteins and cell apoptosis were detected. In addition

nuclear and cytoplasmic separation experiments were carried out on U87 cells before and after Sirt3 knockout

and protein change of p-TFEB was detected. Finally

the change of lysosome membrane protein after overexpression of TFEB and Sirt3 was detected in U87 cells with knocking down and out of Sirt3.

Results

2

Sirt3 was significantly highly expressed in glioma tissue

and the level was closely associated with poor survival of the glioma patients. Sirt3 knockdown significantly enhanced cell apoptosis (

P

<

0.01)

down-regulated the expression of LAMP1

LAMP2 and LAMP2A (

P

<

0.01)

and improved the expression of p-mTOR (

P

<

0.01). Additionally

Sirt3 knockout also

up-regulated p-TFEB protein level in the cytoplasm fraction (

P

<

0.01) while

in the Sirt3 knockout U87 cells

its overexpression reserved the protein levels of LAMP1 and LAMP2 and increased the amount of lysosome. In the Sirt3 knockdown cells

overexpression of TFEB resulted in up-regulation of LAMPs proteins(

P

<

0.01).

Conclusion

2

Sirt3 may affect the nuclear-cytoplasmic distribution of TFEB by regulating the mTOR signaling pathway

up-regulate the expression of LAMPs

enhance the function of lysosome

and then promote the survival and malignant proliferation of glioma cells. Our study suggests that Sirt3 may be a molecular marker for clinical diagnosis and progression of glioma.

关键词

Keywords

references

PETKOVIC M, YALÇIN M, HEESE O, et al . Differential expression of the circadian clock network correlates with tumour progression in gliomas[J ] . BMC Med Genomics, 2023, 16(1): 154. DOI: 10.1186/s12920-023-01585-w.

VERGARA Z, GOMEZ M S, DESVOYES B, et al . Distinct roles of Arabidopsis ORC1 proteins in DNA replication and heterochromatic H3K27me1 deposition[J ] . Nat Commun, 2023, 14(1): 1-13. DOI: 10.1038/s41467-023-37024-8..

XU S C, TANG L, LI X Z, et al . Immunotherapy for glioma: current management and future application[J ] . Cancer Lett, 2020, 476: 1-12. DOI: 10.1016/j.canlet.2020.02.002.

SHI J L, SUN S S, XING S Q, et al . Fraxinellone inhibits progression of glioblastoma via regulating the SIRT3 signaling pathway[J ] . Biomedecine Pharmacother, 2022, 153(1): 113416. DOI: 10.1016/j.biopha.2022.113416..

XU Q C, LIU X Y, MOHSENI G, et al . Mechanism research and treatment progress of NAD pathway related molecules in tumor immune microenvironment[J ] . Cancer Cell Int, 2022, 22(1): 1-21. DOI: 10.1186/s12935-022-02664-1.

VISINTIN R, RAY S K. Intersections of ubiquitin-proteosome system and autophagy in promoting growth of glioblastoma multiforme: challenges and opportunities[J]. Cells, 2022, 11(24): 4063. DOI: 10.3390/cells11244063.

ZHANG J, ZOU L, SHI D F, et al . Structure-guided design of a small-molecule activator of sirtuin-3 that modulates autophagy in triple negative breast cancer[J ] . J Med Chem, 2021, 64(19): 14192-14216. DOI: 10.1021/acs.jmedchem.0c02268.

WANG T S, CAO Y, ZHENG Q, et al . SENP1-Sirt3 signaling controls mitochondrial protein acetylation and metabolism[J ] . Mol Cell, 2019, 75(4): 823-834. e5. DOI: 10.1016/j.molcel.2019.06.008.

GAO G Y, CHEN W W, YAN M J, et al . Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling[J ] . Int J Mol Med, 2020, 45(1): 195-209. DOI: 10.3892/ijmm.2019.4407.

GUSYATINER O, HEGI M E. Glioma epigenetics: from subclassification to novel treatment options[J]. Semin Cancer Biol, 2018, 51: 50-58. DOI: 10.1016/j.semcancer.2017.11.010.

ZHANG H, DAI S H, YANG Y F, et al . Role of sirtuin 3 in degenerative diseases of the central nervous system[J ] . Biomolecules, 2023, 13(5): 735. DOI: 10.3390/biom13050735.

DIKALOVA A E, PANDEY A, XIAO L, et al . Mitochondrial deacetylase Sirt3 reduces vascular dysfunction and hypertension while Sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress[J ] . Circ Res, 2020, 126(4): 439-452. DOI: 10.1161/CIRCRESAHA.119.315767.

ZHAO S J, GONG J F, WANG Y, et al . Sirtuin 3 regulation: a target to alleviate β-hydroxybutyric acid-induced mitochondrial dysfunction in bovine granulosa cells[J ] . J Anim Sci Biotechnol, 2023, 14(1): 18. DOI: 10.1186/s40104-022-00825-w.

KIM T S, JIN Y B, KIM Y S, et al . SIRT3 promotes antimycobacterial defenses by coordinating mitochondrial and autophagic functions[J ] . Autophagy, 2019, 15(8): 1356-1375. DOI: 10.1080/15548627.2019.1582743.

ONORATI A V, DYCZYNSKI M, OJHA R, et al . Targeting autophagy in cancer[J ] . Cancer, 2018, 124(16): 3307-3318. DOI: 10.1002/cncr.31335.

RIZZOLLO F, MORE S, VANGHELUWE P, et al . The lysosome as a master regulator of iron metabolism[J ] . Tren ds Biochem Sci, 2021, 46(12): 960-975. DOI: 10.1016/j.tibs.2021.07.003.

BONAM S R, WANG F J, MULLER S.Lysosomes as a therapeutic target[J]. Nat Rev Drug Discov, 2019, 18(12): 923-948. DOI: 10.1038/s41573-019-0036-1.

MUTVEI A P, NAGIEC M J, HAMANN J C, et al . Rap1-GTPases control mTORC1 activity by coordinating lysosome organization with amino acid availability[J ] . Nat Commun, 2020, 11(1): 1416. DOI: 10.1038/s41467-020-15156-5.

JEONG S J, STITHAM J, EVANS T D, et al . Trehalose causes low-grade lysosomal stress to activate TFEB and the autophagy-lysosome biogenesis response[J ] . Autophagy, 2021, 17(11): 3740-3752. DOI: 10.1080/15548627.2021.1896906.

ZHOU Y J, ZHOU X T, HUANG X J, et al . Lysosome-mediated cytotoxic autophagy contributes to tea polysaccharide-induced colon cancer cell death via mTOR-TFEB signaling[J ] . J Agric Food Chem, 2021, 69(2): 686-697. DOI: 10.1021/acs.jafc.0c07166.

WANG Y, HUANG Y C, CHENG E, et al . LSD1 is required for euchromatic origin firing and replication timing[J ] . Signal Transduct Target Ther, 2022, 7(1): 102. DOI: 10.1038/s41392-022-00927-x.

PENG P, CHEN Z R, ZHANG X L, et al . Construction and verification of an RNA-binding protein-associated prognostic model for gliomas[J ] . Curr Med Sci, 2023, 43(1): 156-165. DOI: 10.1007/s11596-022-2694-1.

PODYACHEVA E, TOROPOVA Y. The role of NAD+, SIRTs interactions in stimulating and counteracting carcinogenesis[J]. Int J Mol Sci, 2023, 24(9): 7925. DOI: 10.3390/ijms24097925.

LIU L G, LI Y, CAO D Y, et al . SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition[J ] . Cancer Lett, 2021, 510(1): 93-104. DOI: 10.1016/j.canlet.2021.04.007.

LIU G Y, SABATINI D M. mTOR at the nexus of nutrition, growth, ageing and disease[J]. Nat Rev Mol Cell Biol, 2020, 21(4): 183-203. DOI: 10.1038/s41580-019-0199-y.

LIU R, ZENG L W, GONG R, et al . mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis[J ] . Nat Commun, 2021, 12(1): 4227. DOI: 10.1038/s41467-021-24321-3.

SAVINI M, FOLICK A, LEE Y T, et al . Lysosome lipid signalling from the periphery to neurons regulates longevity[J ] . Nat Cell Biol, 2022, 24(6): 906-916. DOI: 10.1038/s41556-022-00926-8.

MAHAPATRAK K, MISHRA S R, BEHERA B P, et al . The lysosome as an imperative regulator of autophagy and cell death[J ] . Cell Mol Life Sci, 2021, 78(23): 7435-7449. DOI: 10.1007/s00018-021-03988-3.

朱圣宇, 任超, 姚人骐, 等. 溶酶体损伤与细胞死亡: 疾病治疗新靶点[J]. 生理科学进展, 2021, 52(2): 111-116. DOI: 10.3969/j.issn.0559-7765.2021.02.008.

ZHU S Y, REN C, YAO R Q, et al . Lysosomal injury and cell death: a new target for disease treatment[J ] . Prog Physiol Sci, 2021, 52(2): 111-116. DOI: 10.3969/j.issn.0559-7765.2021.02.008.

SUDHAKAR J N, LU H H, CHIANG H Y, et al . Lumenal Galectin-9-Lamp2 interaction regulates lysosome and autophagy to prevent pathogenesis in the intestine and pancreas[J ] . Nat Commun, 2020, 11(1): 4286. DOI: 10.1038/s41467-020-18102-7.

WANG S G, NI H M, CHAO X J, et al . Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis[J ] . Autophagy, 2019, 15(11): 1954-1969. DOI: 10.1080/15548627.2019.1596486.

QIAO X B, ZHANG Y X, ZHANG Z, et al . KCNJ15 deficiency promotes drug resistance via affecting the fu nction of lysosomes[J ] . Asian J Pharm Sci, 2023, 18(3): 100814. DOI: 10.1016/j.ajps.2023.100814.

WANG S Q, YANG J Y, LIN T T, et al . Excessive production of mitochondrion-derived reactive oxygen species induced by titanium ions leads to autophagic cell death of osteoblasts via the SIRT3/SOD2 pathway[J ] . Mol Med Rep, 2020, 22(1): 257-264. DOI: 10.3892/mmr.2020.11094..

0

浏览量

0

下载量

0

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

相关文章

Rab18作为胶质瘤诊断和进展分子标志物的研究

双氢青蒿素促进胶质瘤GL261细胞的凋亡

PTEN基因对胶质瘤细胞增殖及侵袭性影响的体外研究

缺氧通过驱动M1巨噬细胞极化诱发睾丸间质细胞溶酶体依赖性死亡导致生精功能受损

相关作者

罗绮莉

刘跃平

袁紫林

王刚

莫琼

刁波

尹怡

曹鎏

相关机构

南方医科大学第一临床医学院

中国人民解放军中部战区总医院医学实验科

陆军军医大学（第三军医大学）：，基础医学院免疫学教研室

陆军军医大学（第三军医大学）：，第一附属医院生殖医学中心

陆军军医大学（第三军医大学）第二附属医院病理科

⁰